CSF1R and amyotrophic lateral sclerosis: Supporting these findings, a previous study reveals that systemic administration of CSF1 in another mouse model of ALS (SOD1G37R mouse), which leads to over-activation of peripheral CSF1R, accelerated disease progression but not MN death, highlighting the importance of peripheral CSF1R in ALS pathology18.